Display options
Cite
Bordbar M, Tasbihi M, Kamfiroozi R, et al. Epidemiological and clinical characteristics of neuroblastoma in southern iran. Iran J Ped Hematol Oncol. 2014;4(3):89-96
Bordbar, M., Tasbihi, M., Kamfiroozi, R., & Haghpanah, S. (2014). Epidemiological and clinical characteristics of neuroblastoma in southern iran. Iranian journal of pediatric hematology and oncology, 4(3), 89-96.
Bordbar, Mr, et al. "Epidemiological and clinical characteristics of neuroblastoma in southern iran." Iranian journal of pediatric hematology and oncology vol. 4,3 (2014): 89-96.
Bordbar M, Tasbihi M, Kamfiroozi R, Haghpanah S. Epidemiological and clinical characteristics of neuroblastoma in southern iran. Iran J Ped Hematol Oncol. 2014;4(3):89-96. Epub 2014 Jul 20. PMID: 25254086; PMCID: PMC4173027.
Copy Download .nbib Format: NLM
Share it on

Iran J Ped Hematol Oncol. 2014;4(3):89-96. Epub 2014 Jul 20.

Epidemiological and clinical characteristics of neuroblastoma in southern iran.

Iranian journal of pediatric hematology and oncology

Mr Bordbar, M Tasbihi, R Kamfiroozi, S Haghpanah

Affiliations

  1. Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  2. Amir Oncology Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 25254086 PMCID: PMC4173027

Abstract

BACKGROUND: Neuroblastoma is the third most common malignancy in children with a very heterogeneous feature. In this study, the epidemiological and clinical characteristics of children with neuroblastoma treated in a referral oncology hospital in Shiraz, Southern Iran, were investigated.

MATERIAL AND METHOD: In this historical cohort study, the medical files of 36 children under 18 years old with neuroblastoma were reviewed, who were admitted to Amir Oncology Hospital in Shiraz, Iran from 2006 to 2013. Overall survival and event free survival (EFS) curves were demonstrated by Kaplan Meier methods. Also the effects of demographic and clinical characteristics of the patients on survival were evaluated by Cox regression model.

RESULTS: The median age of diagnosis was 30 months (age range: from 4 to144 months), with M/F ratio of 63.9%. Over 70% of the patients had stage 4 of neuroblastoma at their initial presentations. Adrenal gland comprised 72.2% of the primary tumor site. The most common presenting symptoms were gastrointestinal and constitutional symptoms. The mean overall survival and EFS were 30.75 and 20.56 months, respectively. Among the different variables analyzed, only liver metastasis had an adverse effect on EFS (p=0.025 Hazard ratios 2.83, CI: 1.14-7.02).

CONCLUSION: This study revealed that the majority of children suffering from neuroblastoma in our center are high stage with disseminated disease at the time of detection. It also warns us about an urgent necessity for holding a re-educational program for general practitioners and pediatricians to review the warning signs of common pediatric cancers such as neuroblastoma.

Keywords: Epidemiology; Neuroblastoma; Survival

References

  1. Neoplasia. 2012 Sep;14(9):823-32 - PubMed
  2. Eur J Cancer. 2011 Mar;47(4):561-71 - PubMed
  3. J Clin Oncol. 2009 Jan 10;27(2):298-303 - PubMed
  4. Acta Paediatr Suppl. 1994 Oct;403:1-27 - PubMed
  5. Paediatr Perinat Epidemiol. 2009 Mar;23(2):125-43 - PubMed
  6. Pol J Pathol. 2013 Jun;64(2):149-52 - PubMed
  7. Semin Pediatr Surg. 2012 Feb;21(1):2-14 - PubMed
  8. Nat Rev Cancer. 2003 Mar;3(3):203-16 - PubMed
  9. Cancer. 1992 Sep 15;70(6):1625-33 - PubMed
  10. J Pediatr Hematol Oncol. 2009 Jul;31(7):471-80 - PubMed
  11. BMC Cancer. 2009 Aug 03;9:266 - PubMed
  12. Discov Med. 2010 Jul;10(50):29-36 - PubMed
  13. Br J Cancer. 2009 Mar 10;100(5):853-7 - PubMed
  14. J Clin Oncol. 2010 May 10;28(14):2331-8 - PubMed
  15. Asian Pac J Cancer Prev. 2013;14(5):2739-42 - PubMed
  16. Cancer. 2006 Mar 15;106(6):1409-17 - PubMed
  17. J Korean Med Sci. 2007 Sep;22 Suppl:S66-72 - PubMed
  18. Cancer. 1997 May 15;79(10):2028-35 - PubMed
  19. Eur J Cancer. 2000 May;36(7):901-8 - PubMed
  20. Br Med Bull. 2013;108:173-88 - PubMed
  21. Ann Clin Res. 1983;15 Suppl 39:1-68 - PubMed
  22. Cochrane Database Syst Rev. 2013 Aug 22;(8):CD006301 - PubMed
  23. J Clin Oncol. 1993 Aug;11(8):1466-77 - PubMed
  24. Pediatr Surg Int. 2007 Jul;23(7):637-46 - PubMed

Publication Types